sun pharma stock review

sun pharma stock on last trading session closed
at 890 with loss
on weekly chart, stock is in corrective phase
and that is buying opportunity for traders as well as
medium to long term investors
for traders 800-840 is buying levels with stop loss 750
for target 940 to 960
for medium term to long term investors 700-760 will be best
buy zone with stop loss 600 for target 12424 in next 6 to 12 month time

The Author

Pramod Baviskar

Professional Market Trader And Owner Of Dalal Street Winners Advisory And Coaching Services. Working Since 2007 And Online Presence Since 2010. We Provide Highly Accurate And Professional 1 Entry And 1 Exit Future, Option, Commodity, Currency And Intraday Stock Tips On Whatsapp With Live Support And Follow Up.
COPYRIGHT © 2009-2018. Pramod Baviskar. Dalal street winners advisory and coaching services. FAQ | Disclaimer | Privacy Policy

This website is best viewed using Microsoft Internet Explorer 9 or higher, and/or latest version of Google Chrome and Mozila Firefox browsers.